Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r
NCT00476502 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2012-04-05
Summary
Study of genetic polymorphisms of CYP #A and MDR-1 genes in Thai HIV-1 infected patients on saquinavir/ritonavir.
Conditions
- HIV Infections
Interventions
- GENETIC
-
identify genetic polymorphism in Thai HIV infected
Gene sequencing of Cyp450 metabolic pathway
Sponsors & Collaborators
-
Roche Pharma AG
collaborator INDUSTRY -
The HIV Netherlands Australia Thailand Research Collaboration
lead OTHER
Principal Investigators
-
Kiat Ruxrungtham, MD · The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-02-28
- Primary Completion
- 2008-12-31
- Completion
- 2008-12-31
Countries
- Thailand
Study Locations
More Related Trials
-
Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)
NCT01138267 ·Status: COMPLETED
-
Letermovir in ART-treated HIV-infected Persons
NCT05362916 ·Status: COMPLETED ·Phase: NA
-
Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance
NCT00046033 ·Status: COMPLETED ·Phase: PHASE2
-
Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients
NCT01702090 ·Status: COMPLETED ·Phase: PHASE4
-
Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment
NCT00379405 ·Status: COMPLETED ·Phase: PHASE4
-
Atazavanir/Ritonavir-based HAART in Children
NCT01656109 ·Status: COMPLETED ·Phase: PHASE2
-
A PK and Salvage Study for Children With HIV-infection
NCT00476359 ·Status: COMPLETED ·Phase: PHASE4
-
Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients
NCT02239835 ·Status: TERMINATED ·Phase: PHASE2
-
Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients
NCT00411957 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women.
NCT00145561 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The VMVN Study: Virological Monitoring in Viet Nam
NCT01317498 ·Status: COMPLETED ·Phase: NA
-
Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects
NCT00262522 ·Status: COMPLETED ·Phase: PHASE3
-
The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients
NCT00400738 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women
NCT00621166 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Double-Blind Study of Retrovir in Early HIV Infection
NCT00002045 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Raltegravir in HIV/HCV Co-infected Patients
NCT01225705 ·Status: WITHDRAWN ·Phase: PHASE4
-
TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients
NCT00071097 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand
NCT00197639 ·Status: COMPLETED
-
Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone
NCT01605084 ·Status: WITHDRAWN ·Phase: PHASE3
-
Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy
NCT01606722 ·Status: COMPLETED
-
Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV
NCT00035932 ·Status: COMPLETED ·Phase: PHASE3
-
Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study
NCT01679964 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects
NCT00096746 ·Status: COMPLETED
-
Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy
NCT00357552 ·Status: COMPLETED ·Phase: NA
-
An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
NCT00933205 ·Status: APPROVED_FOR_MARKETING